The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,804,645 in first-year total cost, median $680,433.
Most frequent study sections
- Molecular Cancer Diagnosis and Classification Study Section[MCDC]4
- Special Emphasis Panel[ZRG1 ISB-L (59)]4
- Emerging Imaging Technologies and Applications Study Section[EITA]1
Most frequent institutions
- BOSTON UNIVERSITY MEDICAL CAMPUS1
- EMORY UNIVERSITY1
- FRED HUTCHINSON CANCER CENTER1
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
- LOMA LINDA UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Artificial intelligence enabled Stroma-Weighted Automated Grading system to improve risk stratification in Black Men1R01CA290438-01A1 | AYALA, GUSTAVO ENRIQUEBATRA, SURINDER K.TEWARI, ASHUTOSH K | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $717,667 | MCDC |
| 2025 | Multimodality spatial analysis in prostate cancer to improve prognostic estimation and cast light into the black box of pathology artificial intelligence algorithms1R01CA296792-01 | COOPERBERG, MATTHEW R | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $680,433 | MCDC |
| 2024 | PROSPECT: Premalignant Oral Lesions Pathology and Epigenetic Risk Prediction Tool1R01CA293995-01 | AOUIZERAT, BRADLEY EVIET, CHI T. | LOMA LINDA UNIVERSITY, CA | $710,656 | MCDC |
| 2024 | Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms1R01CA281932-01A1 | BADVE, SUNIL S.GHOSE, SOUMYA | EMORY UNIVERSITY, GA | $614,757 | EITA |
| 2024 | Peptide multimer for early detection of hepatocellular carcinoma1R01CA285303-01A1 | WANG, THOMAS D | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $421,744 | MCDC |
| 2023 | Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer1R01CA281928-01 | SHAH, SOHRAB P | SLOAN-KETTERING INST CAN RESEARCH, NY | $734,548 | ZRG1 |
| 2023 | Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma1R01CA275015-01A1 | LENBURG, MARC ELLIOTTMALDONADO, FABIEN | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $704,857 | ZRG1 |
| 2023 | Identifying lethal prostate cancer at diagnosis with advanced proteoglycomic, radiomic, and genomic approaches1R01CA282022-01 | IPPOLITO, JOSEPH EDWARDKIM, ERIC H | WASHINGTON UNIVERSITY, MO | $637,936 | ZRG1 |
| 2023 | Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer1R01CA281801-01 | CHEN, DELPHINE LLAMPE, PAUL D.ZEGLIS, BRIAN MATTHEW | FRED HUTCHINSON CANCER CENTER, WA | $582,047 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.